Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance

Metabolism: Clinical and Experimental

Volumn 46, Issue 6, 1997, Pages 666-672

  Niskanen, L ^a   Schwab, U S ^b   Sarkkinen, E S ^b   Krusius, T ^b   Vahtera, E ^b   Uusitupa, M I J ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; FAT; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DNA POLYMORPHISM; FAT INTAKE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030959042     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90011-1     Document Type: Article

References (46)

1. Meade TW, Mellows S, Brozovic M, et al: Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 2:533-537, 1986
2. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 118:956-963, 1993
3. Meade TW, Ruddock V, Stirling Y, et al: Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 342:1076-1079, 1993
4. Heinrich J, Balleisen L, Schulte H, et al: Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM Study in healthy men. Arterioscler Thromb 14:54-59, 1994
5. Juhan-Vague I, Thompson SG, Jespersen J: Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. Arterioscler Thromb Vasc Biol 13:1865-1873, 1995
6. Hamsten A, Karpe F, Båvenholm P, et al: Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease. J Intern Med 236:75-88, 1994 (suppl 736)
7. Hamsten A, Wiman B, de Faire U, et al: Increased plasma levels of a rapid inhibitor of plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563, 1985
8. Hamsten A, de Faire U, Walldius G, et al: Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 2:3-9, 1987
9. Thompson SG, Kienast MA, Pyke SDM, et al: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332:635-641, 1995
10. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
11. Vague P, Juhan-Vague I, Aillaud MF, et al: Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35:250-253, 1986
12. Landin K, Stigendahl L, Eriksson E, et al: Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39:1044-1048, 1990
13. Van Loon P, Kluft C, Radder JK, et al: The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism 42:945-949, 1993
14. Andersen P, Seljeflot I, Abdelnoor M, et al: Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism 44:611-616, 1995
15. Panahloo A, Mohamed-Ali V, Lane A, et al: Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasma activator inhibitor gene. Diabetes 44:37-42, 1995
16. Folsom AR: Epidemiology of fibrinogen. Eur Heart J 16:21-24, 1995 (suppl A)
17. Ernst E: Regular exercise reduces fibrinogen levels: A review of the longitudinal studies. Br J Sports Med 27:175-176, 1996
18. Thomas AE, Green FR, Kelleher CH, et al: Variation in the promoter region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 65:487-490, 1991
19. Miller GI, Martin IC, Webster J, et al: Association between dietary fat intake and plasma factor FVII coagulant activity - A predictor of cardiovascular mortality. Atherosclerosis 60:269-277, 1986
20. Hendra TJ, Britton ME, Roper DR, et al: Effects of fish oil supplements in NIDDM subjects. Controlled study. Diabetes Care 13:821-829, 1990
21. Marckmann P, Sandström B, Jespersen J: Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 80:227-233, 1990
22. Folsom AR, Qamhieh HT, Wing RR: Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic variables in moderately overweight adults. Arterioscler Thromb 13:162-169, 1993
23. Marckmann P, Sandström B, Jespersen J: Favourable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 13:505-511, 1993
24. Dawson S, Hamsten A, Wiman B, et al: Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 11:183-190, 1993
25. Salomaa V, Tuomilehto J, Nissinen A, et al: The development of hypertension care in Finland from 1982 to 1987. J Hypertens 7:873-844, 1989
26. World Health Organization: Diabetes mellitus: Report of a WHO study group. WHO Tech Rep Ser 727:1985
27. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993
28. Rastas M, Seppänen R, Knuts L-R, et al (eds): Nutrient Composition of Foods (ed 4). Helsinki Finland, Social Insurance Institution, 1993
29. Uusitupa M, Schwab U, Mäkimattila S, et al: Effects of two high-fat diets with different fatty acid compositions on glucose and lipid metabolism in healthy young women. Am J Clin Nutr 59:1310-1316, 1994
30. Bergman RN: Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38:1512-1527, 1989
31. Pacini G, Bergman RN: MINMOD. A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
32. Penttilä IM, Voutilainen E, Laitinen O, et al: Comparison of different analytical and precipitation methods for the direct estimation of high-density lipoprotein cholesterol. Scand J Clin Lab Invest 41:353-360, 1981
33. Ågren JJ, Julkunen A, Penttilä I: Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column. J Lipid Res 33:1871-1876, 1992
34. Kunkel LM, Smith KD, Boyer SH, et al: Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245-1249, 1977
35. Green F, Kelleher C, Wilkes H, et al: A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 11:540-546, 1991
36. Dawson SJ, Wiman B, Hamsten A, et al: The two allele sequences of common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268:10739-10745, 1993
37. Hultman T, Ståhl S, Homes S, et al: Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res 17:4937-4946, 1989
38. Norusis MJ (ed): SPSS/PC+ 4.0 Base Manual for IBM PC/ XT/AT and PS/2. Chicago, IL, SPSS, 1990
39. Sarkkinen E, Schwab US, Niskanen LK, et al: Monounsaturated-fat enriched diet and polysaturated -fat enriched diet improved lipid metabolism similarly, and had minimal impact on glucose metabolism in subjects with impaired glucose tolerance. Eur J Clin Nutr 50:592-598, 1996
40. Nabulsi AA, Folsom AR, White A, et al: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328:1069-1075, 1993
41. Stefanick ML, Legault C, Tracy RP, et al: Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Arterioscler Thromb Vasc Biol 15:2085-2093, 1995
42. Lane A, Cruickshank JK, Mitchell J, et al: Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. Atherosclerosis 94:43-50, 1992
43. Ginsberg HN: Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care 14:839-855, 1991
44. Uusitupa MIJ, Niskanen LK, Siitonen O, et al: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
45. Mehrabian M, Peter JB, Barnard RJ, et al: Dietary regulation of fibrinolytic factors. Atherosclerosis 84:25-32, 1990
46. Mansfield MW, Stickland MH, Grant PJ: Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in caucasian subjects with non-insulin-dependent diabetes mellitus. Thromb Haemost 74:842-847, 1995